| Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia S Akhondzadeh, F Rezaei, B Larijani, AA Nejatisafa, L Kashani, ... Schizophrenia research 84 (2-3), 405-410, 2006 | 199 | 2006 |
| N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study M Farokhnia, A Azarkolah, F Adinehfar, MR Khodaie-Ardakani, ... Clinical neuropharmacology 36 (6), 185-192, 2013 | 168 | 2013 |
| Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia: an 8-week, randomized, double-blind, placebo-controlled study A Modabbernia, F Rezaei, B Salehi, M Jafarinia, M Ashrafi, M Tabrizi, ... CNS drugs 27, 57-65, 2013 | 128 | 2013 |
| Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania Z Amrollahi, F Rezaei, B Salehi, AH Modabbernia, A Maroufi, ... Journal of affective disorders 129 (1-3), 327-331, 2011 | 113 | 2011 |
| Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ... Psychiatry research 215 (3), 540-546, 2014 | 108 | 2014 |
| Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei, M Farokhnia, ... Bipolar disorders 17 (6), 606-614, 2015 | 99 | 2015 |
| The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial SH Abbasi, H Behpournia, A Ghoreshi, B Salehi, M Raznahan, ... Schizophrenia research 116 (2-3), 101-106, 2010 | 95 | 2010 |
| Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study F Rezaei, M Mohammad-Karimi, S Seddighi, A Modabbernia, M Ashrafi, ... Journal of clinical psychopharmacology 33 (3), 336-342, 2013 | 74 | 2013 |
| Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial F Rezaei, M Emami, S Zahed, MJ Morabbi, M Farahzadi, S Akhondzadeh DARU Journal of Pharmaceutical Sciences 23, 1-8, 2015 | 56 | 2015 |
| A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders E Hasanzadeh, MR Mohammadi, A Ghanizadeh, SA Rezazadeh, ... Child Psychiatry & Human Development 43, 674-682, 2012 | 53 | 2012 |
| Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial G Kianimehr, F Fatehi, S Hashempoor, MR Khodaei-Ardakani, F Rezaei, ... DARU Journal of Pharmaceutical Sciences 22, 1-7, 2014 | 50 | 2014 |
| Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: A randomized, double-blind comparison trial S 7. Zarinara, A.-R., Mohammadi, M.-R., Hazrati, N., Tabrizi, M., Rezazadeh ... Human Psychopharmacology 25 (7-8), 530-535, 2010 | 47* | 2010 |
| Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial S Akhondzadeh, R Ghayyoumi, F Rezaei, B Salehi, AH Modabbernia, ... Psychopharmacology 213, 809-815, 2011 | 45 | 2011 |
| A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia M Farokhnia, M Sabzabadi, H Pourmahmoud, MR Khodaie-Ardakani, ... Psychopharmacology 231, 533-542, 2014 | 44 | 2014 |
| A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia M Noroozian, S Ghasemi, SMR Hosseini, A Modabbernia, ... Psychopharmacology 228, 595-602, 2013 | 43 | 2013 |
| Topiramate for the management of methamphetamine dependence: a pilot randomized, double‐blind, placebo‐controlled trial F Rezaei, E Ghaderi, R Mardani, S Hamidi, K Hassanzadeh Fundamental & clinical pharmacology 30 (3), 282-289, 2016 | 42 | 2016 |
| Relationship between attachment styles and happiness in medical students M Moghadam, F Rezaei, E Ghaderi, N Rostamian Journal of family medicine and primary care 5 (3), 593-599, 2016 | 40 | 2016 |
| L‐carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double‐blind study S Arabzadeh, M Shahhossenie, B Mesgarpour, F Rezaei, MR Shalbafan, ... Human Psychopharmacology: clinical and experimental 32 (4), e2584, 2017 | 38 | 2017 |
| Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double‐blind and placebo‐controlled randomized trial F Hendouei, H Sanjari Moghaddam, MR Mohammadi, N Taslimi, ... Journal of clinical pharmacy and therapeutics 45 (2), 324-334, 2020 | 35 | 2020 |
| Simvastatin adjunct therapy for negative symptoms of schizophrenia: a randomized double-blind placebo-controlled trial S Tajik-Esmaeeli, E Moazen-Zadeh, N Abbasi, SV Shariat, F Rezaei, ... International Clinical Psychopharmacology 32 (2), 87-94, 2017 | 34 | 2017 |
